Gabriel Eckermann

Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

Chronic Social Stress Inhibits Cell Proliferation in the Adult Medial Prefrontal Cortex: Hemispheric Asymmetry and Reversal by Fluoxetine Treatment

Depression

Major depressive disorder

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?

Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects

Inflammation and depression: a causal or coincidental link to the pathophysiology?

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Recent advances in SPME techniques in biomedical analysis

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review

Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study

ABCB1 and Cytochrome P450 Polymorphisms

IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure−Property−Activity Relation Model

Adenosine 5'-phosphorothioate. A nucleotide analog that is a substrate, competitive inhibitor, or regulator of some enzymes that interact with adenosine 5'-phosphate

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Adenosine 5′-0(3-thiotriphosphate) in the control of phosphorytase activity

Molecular imprinting: perspectives and applications

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Therapeutic Monitoring of Psychotropic Drugs

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants

Inhibition of alcohol dehydrogenase from yeast by pyridine

Clozapine Case Series

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry